Emma Baker
- Systemic inflammation is enhanced by acute hyperglycaemia and suppressed by insulin in COPDBy John Archer and Emma BakerJohn ArcherCentre of Clinical Pharmacology, St George's University, University of London, London, United KingdomEmma BakerCentre of Clinical Pharmacology, St George's University, University of London, London, United Kingdom
- Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPDBy John Archer and Emma BakerJohn ArcherCentre for Clincal Pharmacology, St George's University, University of London, London, United KingdomEmma BakerCentre for Clincal Pharmacology, St George's University, University of London, London, United Kingdom
- Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failureBy Mohani Bajaj, Andrew Tappouni, Michael Tumilty, James Dodd, Paul Jones and Emma BakerMohani Bajaj1Institute of Infection and Immunity, St George's, University of London, London, United KingdomAndrew Tappouni1Institute of Infection and Immunity, St George's, University of London, London, United KingdomMichael Tumilty1Institute of Infection and Immunity, St George's, University of London, London, United KingdomJames Dodd2Academic Respiratory Unit, Southmead Hospital, Bristol, United KingdomPaul Jones1Institute of Infection and Immunity, St George's, University of London, London, United KingdomEmma Baker1Institute of Infection and Immunity, St George's, University of London, London, United Kingdom
- Female pulmonary arterial hypertension is associated with decreased microRNA96 expressionBy Emma Wallace, Kirsty Mair, Lu Long, Xu D. Yang, Nick Morrell, Andrew H. Baker and Margaret R. MacLeanEmma Wallace1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United KingdomKirsty Mair1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United KingdomLu Long2School of Clinical Medicine, University of Cambridge, Cambridge, United KingdomXu D. Yang2School of Clinical Medicine, University of Cambridge, Cambridge, United KingdomNick Morrell2School of Clinical Medicine, University of Cambridge, Cambridge, United KingdomAndrew H. Baker1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United KingdomMargaret R. MacLean1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
- Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbationsBy Andrew Tappouni, Mohani Bajaj, Michael Tumilty, James Dodd, Paul Jones and Emma BakerAndrew Tappouni1Institute of Infection and Immunity, St George's, University of London, London, United KingdomMohani Bajaj1Institute of Infection and Immunity, St George's, University of London, London, United KingdomMichael Tumilty1Institute of Infection and Immunity, St George's, University of London, London, United KingdomJames Dodd2Academic Respiratory Unit, Southmead Hospital, Bristol, United KingdomPaul Jones1Institute of Infection and Immunity, St George's, University of London, London, United KingdomEmma Baker1Institute of Infection and Immunity, St George's, University of London, London, United Kingdom
- Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial*): No impact on hospital admissions and quality of life (QOL)By Michelle Chatwin, George Hawkins, Lydia Paniccia, Annette Woods, Rebecca Lucas, Anna Hanak, Essam Ramhamadany, Emma Baker, Bobby Mann, Jillian Riley, Martin Cowie and Anita SimondsMichelle Chatwin1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomGeorge Hawkins1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomLydia Paniccia1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomAnnette Woods1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomRebecca Lucas1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomAnna Hanak1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomEssam Ramhamadany3Department of Respiratory Medicine, West Middlesex University Hospital, London, United KingdomEmma Baker2Department of Respiratory Medicine, St Georges Hospital, London, United KingdomBobby Mann3Department of Respiratory Medicine, West Middlesex University Hospital, London, United KingdomJillian Riley1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomMartin Cowie1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomAnita Simonds1NIHR Respiratory and Cardiology BioMedical Research Units, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom
- Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatmentBy Amr Alderawi, Simon Dunmore, Gaetano Caramori, Andrew Hitchings, Emma Baker and Paul KirkhamAmr Alderawi1School of Biomedical Science & Physiology, University of Wolverhampton, Wolverhampton, United KingdomSimon Dunmore1School of Biomedical Science & Physiology, University of Wolverhampton, Wolverhampton, United KingdomGaetano Caramori2Department of Respiratory Medicine, University of Ferrara, Ferarra, ItalyAndrew Hitchings3Department of Respiratory Medicine, St Georges University Hospital, London, United KingdomEmma Baker3Department of Respiratory Medicine, St Georges University Hospital, London, United KingdomPaul Kirkham1School of Biomedical Science & Physiology, University of Wolverhampton, Wolverhampton, United Kingdom
- Glucose and lactate concentrations in the distal lung are modified by hyperglycaemia and inflammationBy Cecilia Nagorny Holmberg, Cecilia Wingren, Annika Åstrand, John Taylor, James Garnett, Emma Baker and Deborah BainesCecilia Nagorny Holmberg1RIA Bioscience, AstraZeneca R&D Mölndal, Mölndal, SwedenCecilia Wingren1RIA Bioscience, AstraZeneca R&D Mölndal, Mölndal, SwedenAnnika Åstrand1RIA Bioscience, AstraZeneca R&D Mölndal, Mölndal, SwedenJohn Taylor1RIA Bioscience, AstraZeneca R&D Mölndal, Mölndal, SwedenJames Garnett2Institute for Infection and Immunology, St George's, University of London, London, United KingdomEmma Baker2Institute for Infection and Immunology, St George's, University of London, London, United KingdomDeborah Baines2Institute for Infection and Immunology, St George's, University of London, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.